"Dark corridors" in 5-ALA resection of high-grade gliomas: combining fluorescence-guided surgery and contrast-enhanced ultrasonography to better explore the surgical field.

BACKGROUND Increasing the extent of resection (EOR) is considered a main goal in high grade glioma (HGG) surgery. Significant advancements have been recently made to assist surgery: namely the use of 5-aminolevulinic acid (5ALA) and the application of contrast-enhanced ultrasound (CEUS) embody two of the most recently introduced tools in the neuro-oncology field. A combined approach including the two techniques has been suggested in literature. Our primary aim is to identify in which conditions CEUS final survey has a real impact in a 5-ALA guided context and assess which preoperative tumor characteristics, with specific attention to working corridors can predict strains of the fluorescence guided procedure and hence recommend the use of the combined technique. METHODS Forty-nine HGG glioma surgeries were performed at our institution with the abovementioned protocol between January 2016 and June 2016. Based on preoperative MRI, we stratified glioma characteristics according to three determinants: localization (deep versus superficial), size (<3.5 versus >3.5 cm) and shape (regular versus irregular). RESULTS CEUS modified 5-ALA guided resection in 11 cases (22.45%): this appeared to be associated with statistically significance to deep tumor localization (P=0.04) and irregular/multi-lobulated margins (P=0.003). On the other hand, tumor size alone did not appear as a statistically significant determinant. CONCLUSIONS When dark corridors are presents or when overlying brain parenchyma hinders illumination, drawbacks to the 5-ALA assistance can be expected, hence CEUS final survey has a crucial role of 'refinement'. In those selected cases, an integrated 5ALA+CEUS protocol was shown as advisable in EOR improvement.

[1]  A. Olivi,et al.  Erratum to 'Contrast-Enhanced Ultrasonography and Color Doppler: Guided Intraoperative Embolization of Intracranial Highly Vascularized Tumors' [World Neurosurgery 128 (2019) 547-555]. , 2019, World neurosurgery.

[2]  G. Sabatino,et al.  Significance of H3K27M mutation in 'non midline' high grade gliomas of the cerebral hemispheres. , 2019, World neurosurgery.

[3]  A. Mangiola,et al.  Reliability of intraoperative ultrasound in detecting tumor residual after brain diffuse glioma surgery: a systematic review and meta-analysis , 2019, Neurosurgical Review.

[4]  Alessandro Olivi,et al.  CEUS and Color Doppler - guided intraoperative embolization of intracranial highly vascularized tumors. , 2019, World neurosurgery.

[5]  G. Sabatino,et al.  'Enhancing vision' in high grade glioma surgery: A feasible integrated 5-ALA + CEUS protocol to improve radicality. , 2019, World neurosurgery.

[6]  V. Rizzo,et al.  Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection. , 2019, World neurosurgery.

[7]  F. Angileri,et al.  The role of navigated transcranial magnetic stimulation for surgery of motor-eloquent brain tumors: a systematic review and meta-analysis , 2019, Clinical Neurology and Neurosurgery.

[8]  T. Ius,et al.  Application of Indocyanine Green video angiography in vascular neurosurgery. , 2020, Journal of neurosurgical sciences.

[9]  F. Esposito,et al.  Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection. , 2019, Journal of neurosurgical sciences.

[10]  Jacob S. Young,et al.  Perioperative outcomes following reoperation for recurrent insular gliomas. , 2019, Journal of neurosurgery.

[11]  Walter Stummer,et al.  Established and emerging uses of 5-ALA in the brain: an overview , 2019, Journal of Neuro-Oncology.

[12]  Jonathan T. C. Liu,et al.  Visualization technologies for 5-ALA-based fluorescence-guided surgeries , 2018, Journal of Neuro-Oncology.

[13]  F. DiMeco,et al.  Advanced Ultrasound Imaging in Glioma Surgery: Beyond Gray-Scale B-mode , 2018, Front. Oncol..

[14]  S. Kalkanis,et al.  The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience , 2018, Journal of Neuro-Oncology.

[15]  A. Olivi,et al.  Intra-Operative Ultrasound: Tips and Tricks for Making the Most in Neurosurgery. , 2018, Surgical technology international.

[16]  Francesco Tomasello,et al.  The Impact of Diffusion Tensor Imaging Fiber Tracking of the Corticospinal Tract Based on Navigated Transcranial Magnetic Stimulation on Surgery of Motor-Eloquent Brain Lesions , 2018, Neurosurgery.

[17]  F. DiMeco,et al.  Contrast-enhanced ultrasound (CEUS) in spinal tumor surgery , 2018, Acta Neurochirurgica.

[18]  Iluminada Baturone,et al.  A PUF- and Biometric-Based Lightweight Hardware Solution to Increase Security at Sensor Nodes , 2018, Sensors.

[19]  A. Olivi,et al.  Comment on the article "Real-time intraoperative contrast-enhanced ultrasound (CEUS) in vascularized spinal tumors: a technical note" , 2018, Acta Neurochirurgica.

[20]  A. Olivi,et al.  Real-time intraoperative contrast-enhanced ultrasound (CEUS) in vascularized spinal tumors: a technical note , 2018, Acta Neurochirurgica.

[21]  C. Dietrich,et al.  Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten Ultraschalls (CEUS) bei nicht-hepatischen Anwendungen : Update 2017 (Langversion) , 2018 .

[22]  A. Olivi,et al.  Integration of Real-Time Intraoperative Contrast-Enhanced Ultrasound and Color Doppler Ultrasound in the Surgical Treatment of Spinal Cord Dural Arteriovenous Fistulas. , 2018, World neurosurgery.

[23]  Mirko D'Onofrio,et al.  The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) , 2018, Ultraschall in der Medizin - European Journal of Ultrasound.

[24]  Mitchel S. Berger,et al.  Surgical oncology for gliomas: the state of the art , 2018, Nature Reviews Clinical Oncology.

[25]  G. Spena,et al.  Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area , 2018, Clinical Neurology and Neurosurgery.

[26]  Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note. , 2017, Journal of neurosurgery.

[27]  S. Merler,et al.  Impact of mass effect, tumor location, age, and surgery on the cognitive outcome of patients with high-grade gliomas: a longitudinal study. , 2017, Neuro-oncology practice.

[28]  G. Sabatino,et al.  Angio-Architectural Features of High-Grade Intracranial Dural Arteriovenous Fistulas: Correlation With Aggressive Clinical Presentation and Hemorrhagic Risk , 2017, Neurosurgery.

[29]  Binsheng Zhao,et al.  Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. , 2017, Journal of neurosurgery.

[30]  C. Wirtz,et al.  Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging. , 2017, Journal of neurosurgical sciences.

[31]  C. Olivieri,et al.  Fluorescein‐guided intraoperative endoscopy in patients with hereditary hemorrhagic telangiectasia: first impressions , 2017, International forum of allergy & rhinology.

[32]  M. Bernstein,et al.  The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic review , 2016, Cancer.

[33]  P. Gaetani,et al.  Low-Cost Fluorescein Detection System for High-Grade Glioma Surgery. , 2016, World neurosurgery.

[34]  A. Unterberg,et al.  Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI: analysis from a prospective single-center registry of supratentorial gliomas. , 2016, Neurosurgical focus.

[35]  Luigi Solbiati,et al.  Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. , 2016, Neurosurgical focus.

[36]  S. Paratore,et al.  Portable Intraoperative Computed Tomography Scan in Image-Guided Surgery for Brain High-grade Gliomas: Analysis of Technical Feasibility and Impact on Extent of Tumor Resection , 2016, Operative neurosurgery.

[37]  E. Hattingen,et al.  Combination of Intraoperative Magnetic Resonance Imaging and Intraoperative Fluorescence to Enhance the Resection of Contrast Enhancing Gliomas. , 2015, Neurosurgery.

[38]  A. Albanese,et al.  Diagnosis and management of dural arteriovenous fistulas: A 10 years single-center experience , 2015, Clinical Neurology and Neurosurgery.

[39]  F. DiMeco,et al.  Intraoperative cerebral ultrasound for third ventricle colloid cyst removal: case report , 2016, Journal of Ultrasound.

[40]  Carmen Terranova,et al.  Preoperative functional mapping for rolandic brain tumor surgery , 2014, Neuroscience Letters.

[41]  G. Maira,et al.  Indocyanine green video-angiography in neurosurgery: A glance beyond vascular applications , 2014, Clinical Neurology and Neurosurgery.

[42]  H. Steiger,et al.  Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note. , 2014, World neurosurgery.

[43]  L. Solbiati,et al.  Intraoperative Cerebral Glioma Characterization with Contrast Enhanced Ultrasound , 2014, BioMed research international.

[44]  F. DiMeco,et al.  Intraoperative ultrasound in spinal tumor surgery , 2014, Journal of Ultrasound.

[45]  L. Solbiati,et al.  Intraoperative contrast-enhanced ultrasound for brain tumor surgery. , 2014, Neurosurgery.

[46]  J. Honegger,et al.  Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[47]  Xiaofeng Chen,et al.  Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid–Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies , 2013, PloS one.

[48]  Jörg-Christian Tonn,et al.  Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. , 2008, Clinical neurosurgery.

[49]  Y. Kajimoto,et al.  Endoscopic identification and biopsy sampling of an intraventricular malignant glioma using a 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging system. Technical note. , 2007, Journal of neurosurgery.